POXEL |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.447 EUR | -0.67% |
|
-10.00% | -13.96% |
| 04-11 | Poxel: CDC falls below the 10% threshold | CF |
| 02-15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| POXEL | Bio Therapeutic Drugs | -0.67% | -10.00% | - | - | - | 25.36M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- POXEL Stock
- 7PO Stock
- Charts Poxel
- Comparison Chart
